Skip to content

Occupational Hand Eczema - Testing of a Prevention-concept

Occupational Hand Eczema - Establishment and Testing of a Prevention-concept With Focus on the Young Workforce

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04790799
Enrollment
50
Registered
2021-03-10
Start date
2020-07-02
Completion date
2023-06-14
Last updated
2023-11-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Occupational Contact Dermatitis

Brief summary

Randomised controlled trial examining the effect of decreased waiting time for the first doctors' appointment, patient education, glove counselling and counselling at departments of social or occupational medicine on severity of hand eczema, quality of life, use of corticosteroids, and jobsituation 3-12 months after intervention in patients with suspected occupational contact dermatitis of the hands.

Detailed description

Patients with suspected occupational hand eczema are recruited to the study on basis of their referral from general practitioner to dermatologist. Patients are randomised to either control or intervention group. The control group is treated and followed-up by the dermatologist they have been referred to, while the intervention group is treated and followed-up at Gentofte Hospital skin department with a maximum waiting time of 3 weeks. At the skin department at Gentofte Hospital, the patients in the intervention group receive patient education in prevention and treatment of hand eczema, glove counselling, personal product screening by a chemistry engineer, extended allergy testing and the standard treatment of hand eczema. Patients in both the control and intervention group are asked to fill out a questionnaire at 3, 6, 9 and 12 months after inclusion in the study. The questionnaire contains questions about quality of life, severity of hand exzema, jobsituation, use of healthcare service and use of medicine. Furthermore, prescriptions of medicine are registered in both control and intervention group at 3, 6, 9 and 12 months.

Interventions

OTHERTreatment at the skin department at Gentofte Hospital

Treatment in a hospital setting at Gentofte Hospital skin department

Sponsors

Arbejdsmiljøforskningsfonden
CollaboratorUNKNOWN
Bispebjerg Hospital
CollaboratorOTHER
Frederiksberg University Hospital
CollaboratorOTHER
National Research Centre for the Working Environment, Denmark
CollaboratorOTHER_GOV
University of Osnabrueck
CollaboratorOTHER
National Allergy Research Center, Denmark
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
15 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* Referred from a general practitioner to a dermatologist * Hand eczema within the last 3 months * Suspicion that the hand eczema is work-related (either patient and/or doctors suspicion)

Exclusion criteria

* Does not read and write danish * Severe psychiatric illness * Pregnancy

Design outcomes

Primary

MeasureTime frameDescription
Change in severity of handeczema assessed by the hand eczema severity index (HECSI) 0-360 points (0 best, 360 worst)Change between baseline and 3 monthsThe hand eczema severity index (HECSI)
Change in severity of handeczema assessed by the photographic guide for severity of handeczemaChange between baseline and 3 monthsSelf-assessed photographic guide
Change in severity of handeczema assessed by a visual analog score 0-100 (0 best, 100 worst)Change between baseline and 3 monthsVisual analog Score for severity of handeczema
Amount of corticosteroids prescribed within the last yearBaselineAmount of corticosteroids prescribed wihtin the last year
Amount of corticosteroids prescribed within the last 3 months3 monthsAmount of corticosteroids prescribed within the last 3 months
Health-Related Quality of Life assessed by Skindex-29, scale ranging from 0-100 points (higher score = higher impact of skin disease on quality of life)BaselineSkindex-29
Health-Related Quality of Life assessed by European Quality of Life - 5 Dimensions (EQ-5D)BaselineEuropean Quality of Life - 5 Dimensions (EQ-5D)
Health-Related Quality of Life assessed by Dermatology life quality index (DLQI) 0-30 (higher score = higher impact of skin disease on quality of life)BaselineDermatology life quality index (DLQI)
Number of participants with loss of job within the last yearBaselineSelf-repported loss of job wihtin the last year
Number of participants with loss of job within the last 3 monthsBaselineSelf-repported loss of job within the last 3 months
Amount of sick leave within the last yearBaselineSelf-repported amount of sick leave within the last year
Amount of sick leave within the last 3 months3 monthsSelf-repported amount of sick leave within the last 3 months
Number of participants with change of occupation due to occupational contact dermatitis within the last yearBaselineChange of occupation due to occupational contact dermatitis within the last year
Number of participants with change of occupation due to occupational contact dermatitis within the last 3 months3 monthsChange of occupation due to occupational contact dermatitis within the last 3 months

Countries

Denmark

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026